Clinical trial Recruiting at 35 sites Interventional Ages 65 and up

Preventing atrial fibrillation with surgical ablation and left atrial appendage clipping during heart surgery

Official title: EnCompass Clamp and the AtriClip in Box Lesion and Left Atrial Appendage EXclusion Procedure for the Prevention of New Onset of Atrial Fibrillation

Run by AtriCure, Inc. · NCT06989775 · Data updated 2026-11-12

This trial tests whether adding surgical ablation and clipping of the left atrial appendage during routine open-heart surgery can prevent postoperative and later atrial fibrillation in older patients at higher stroke risk.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment960 (estimated)
SponsorAtriCure, Inc.
Industry-sponsored
Locations37 sites (Scottsdale, Arizona and 36 other locations)
StatusRecruiting
StartedOctober 24, 2025
Main results expectedFebruary 2027
Study endsDecember 2029
Registry record updatedOctober 7, 2026
Trial IDNCT06989775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 65 or older with CHA2DS2-VASc ≥ 3 who are scheduled for cardiac surgery requiring cardiopulmonary bypass and opening of the pericardium and who have no prior history of AF or prior pericardial procedures.

Probably not a fit

Patients with any prior documented atrial fibrillation or flutter, prior LAA exclusion, off-pump surgery, prior pericardial opening, or other exclusionary conditions (for example infiltrative cardiomyopathy, active infection, NYHA class IV, or ventricular arrhythmia) are not expected to benefit from this prophylactic approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

BoxX-NoAF randomizes patients without prior atrial fibrillation who are undergoing cardiac surgery with cardiopulmonary bypass to receive prophylactic left atrial ablation plus left atrial appendage (LAA) exclusion or to usual surgical care. The intervention uses the Isolator® Synergy™ EnCompass® Ablation System for lesion creation and the AtriClip® device for LAA exclusion at the time of the index operation. Patients are enrolled at several US centers and followed for postoperative AF and longer-term clinical atrial fibrillation outcomes. The trial targets older patients with elevated CHA2DS2-VASc scores who are at higher risk of developing AF but have not previously had AF or undergone pericardial surgery.

Why it matters

Potential benefit: If successful, this approach could reduce the rate of postoperative AF and lower long-term atrial fibrillation-related complications such as stroke and readmission.

How similar studies have gone: Surgical ablation and LAA exclusion have shown benefit for patients with existing AF, but prophylactic ablation and LAA exclusion in patients without prior AF is relatively novel and has limited direct evidence to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Planned and clinically indicated for cardiac surgical procedure requiring cardiac bypass and opening of the pericardium
* Age ≥ 65 years and CHA2DS2-VASc ≥ 3

Exclusion Criteria:

* Documented history of atrial fibrillation or atrial flutter anytime prior to the cardiac surgery
* Prior procedure involving opening the pericardium or entering the pericardial space
* Patients undergoing off-pump surgery
* Prior LAA occlusion, exclusion, or removal (surgical or percutaneous)
* Presence of a permanent pacemaker
* Infiltrative cardiomyopathies (i.e. amyloidosis)
* Planned cardiac surgical procedure using non-sternotomy approaches
* Patients whose planned procedure is a heart transplant or implantation of any long-term ventricular assist devices
* Presence of ventricular arrhythmia
* Active endocarditis
* NYHA Class IV heart failure symptoms
* Preoperative need for an intra-aortic ballon pump or intravenous inotropes
* Active systemic infection at the time of cardiac surgery requiring antibiotics
* Known allergy to Nitinol or nickel sensitivity
* Known medical condition with expected survival of less than 1 year
* Other comorbidities that in the Investigator's opinion make the subject unsuitable candidate to complete the protocol required intervention or visits
* Current enrollment in an investigation or trial or an investigational devices or investigational drug that would interfere with this trial
* Mental impairment or other psychiatric conditions which may not allow the patient to understand the nature, significance, and scope of the trial.
* Pregnancy
* Known severe symptomatic carotid disease

Where it's running

  • Honor Health
    Scottsdale, Arizona, United States
    Recruiting
  • St. Bernards Medical Center
    Jonesboro, Arkansas, United States
    Recruiting
  • Sharp Memorial Hospital
    San Diego, California, United States
    Recruiting
  • Adventist Health St. Helena
    St. Helena, California, United States
    Recruiting
  • Morton Plant Hospital - BayCare Health System, Inc.
    Clearwater, Florida, United States
    Recruiting
  • St. Joseph's Hospital - BayCare Health System, Inc.
    Clearwater, Florida, United States
    Recruiting
Show 31 more locations
  • Naples Comprehensive Health
    Naples, Florida, United States
    Recruiting
  • Orlando Health, Inc.
    Orlando, Florida, United States
    Recruiting
  • Sarasota Memorial Hospital
    Sarasota, Florida, United States
    Recruiting
  • Emory University
    Atlanta, Georgia, United States
    Recruiting
  • Piedmont Hospital
    Atlanta, Georgia, United States
    Recruiting
  • Wellstar Health System
    Marietta, Georgia, United States
    Recruiting
  • Northwestern Memorial Hospital
    Chicago, Illinois, United States
    Recruiting
  • Norton Healthcare
    Louisville, Kentucky, United States
    Recruiting
  • MedStar Health Research Institute
    Baltimore, Maryland, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • Corewell Health
    Grand Rapids, Michigan, United States
    Recruiting
  • Trinity Health
    Ypsilanti, Michigan, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • BJC Healthcare (Washington University)
    St Louis, Missouri, United States
    Recruiting
  • Northwell Health
    Manhasset, New York, United States
    Recruiting
  • Bethesda North Hospital
    Cincinnati, Ohio, United States
    Recruiting
  • Cleveland Clinic Foundation
    Cleveland, Ohio, United States
    Recruiting
  • Promedica Toledo Hospital
    Toledo, Ohio, United States
    Recruiting
  • Allegheny-Singer Research Institute
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Centennial Medical Center
    Nashville, Tennessee, United States
    Recruiting
  • Ascension Saint Thomas
    Nashville, Tennessee, United States
    Recruiting
  • St David's HealthCare
    Austin, Texas, United States
    Recruiting
  • Baylor Research Institute - Baylor Scott and White Research Institute
    Dallas, Texas, United States
    Recruiting
  • Charleston Area Medical Center
    Charleston, West Virginia, United States
    Recruiting
  • Aspirus Hospital
    Wausau, Wisconsin, United States
    Recruiting
  • Royal Columbian Hospital
    New Westminster, British Columbia, Canada
    Recruiting
  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting
  • London Health Sciences Centre, University Hospital
    London, Ontario, Canada
    Recruiting
  • Montreal Heart Institute
    Montreal, Quebec, Canada
    Recruiting
  • New York Presbyterian Hospital/Columbia University Irving Medical Center
    New York, New York, United States
    Not yet recruiting
  • Methodist San Antonio
    San Antonio, Texas, United States
    Withdrawn

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.